Detailed explanation of the efficacy and side effects of Brivaracetam/Brivaracetam

Brivaracetam/Brivaracetam is a new generation of anti-epileptic drugs whose main indication is the treatment of focal epileptic seizures in patients over 12 years of age. It reduces the excessive activation of synaptic transmission in neurons by selectively binding to the neuronal synaptic vesicle protein SV2A, thereby inhibiting the propagation of epileptic discharges. This mechanism is similar to the older generation anti-epileptic drug levetiracetam, but brivaracetam has a higher affinity for SV2A and therefore exhibits better efficacy and fewer psychiatric side effects in some patients.

In terms of therapeutic efficacy, brivaracetam has been shown to have stable clinical advantages in significantly reducing the frequency of focal seizures, especially in patients who have poor response or tolerance to other anti-epileptic drugs. It has a fast onset of action and a short time to reach peak blood concentration, which helps to quickly control epileptic activity. At the same time, due to its good pharmacokinetic characteristics, including low protein binding rate, inactive toxic metabolites, and minimal impact on renal function, it is suitable for use in patients with a variety of comorbidities.

In terms of safety, the side effects of brivaracetam are generally mild, but they still require attention. The most common adverse reactions include drowsiness, dizziness, fatigue, nausea and upper respiratory tract infection. These side effects are mostly mild to moderate, usually appear at the beginning of treatment, and may resolve on their own as treatment continues. Some patients may also experience mood swings, depression, or aggressive tendencies, although the incidence is low, but special vigilance should be exercised in those with a history of mental illness.

Of note, brivaracetam may be less likely to induce mood abnormalities than levetiracetam and may therefore have a clinical advantage in patients with poor tolerance for psychiatric side effects. However, in rare cases, drug allergy or more serious adverse events may still occur, so it is recommended that patients maintain regular follow-up during medication and report any abnormal reactions in a timely manner.

Reference materials:https://www.briviact.com/